Bristle is an early-stage venture-backed startup company aiming to prevent oral disease and improve oral health outcomes through our unique platform that analyzes the oral microbiome.
Our mission is to enable preventative oral health treatments, develop novel therapeutics to improve oral health and democratize access to oral health care. We believe an ounce of prevention is worth a pound of cure.
🦷 Oral diseases, such as cavities, gum disease, and halitosis, stem from an overabundance of bacterial pathogens that are part of a community of bacteria, fungi, and viruses also known as the oral microbiome.
We have developed a platform to identify the root causes of oral diseases by profiling the oral microbiome. Our at-home saliva test detects the bacteria that cause bad breath, cavities, and gum disease. We then provide personalized recommendations tailored to an users oral microbiome to prevent oral disease from progressing irreversibly.
Through the comprehensive unbiased profiling of the oral microbiome, we are poised to make discoveries that advance our basic understanding of science. Our platform enables the exploration of associations between the oral microbiome and health, facilitating the development of novel therapeutic drugs that target the oral microbiome to improve health outcomes.